GlassScriptPhysician profile
Gihan E Dawood
NPI 1255489746
$21,559.73
in general payments reported to CMS, 2019-2025
10 companies · $763 in 2025
The $763 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,934 · 2020: $126 · 2024: $19K · 2025: $763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Travel and Lodging: $1,682 · Food and Beverage: $1,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $16,390.00 |
| Travel and Lodging | $1,682.19 |
| Food and Beverage | $1,427.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $17,081.41 | 2024-2025 | Evenity |
| Medtronic Minimed, INC. | $1,714.23 | 2019-2020 | |
| Tandem Diabetes Care, INC. | $1,689.65 | 2019-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Medtronic, INC. | $379.22 | 2025 | Minimed 780g |
| Novo Nordisk INC | $233.95 | 2019-2025 | |
| Dexcom, INC. | $166.21 | 2020-2025 | Dexcom G7 Gss (161) |
| Abbott Laboratories | $115.75 | 2019 | |
| Alexion Pharmaceuticals, INC. | $84.22 | 2025 | Strensiq |
| Radius Health, INC. | $50.56 | 2025 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $44.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gihan Dawood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.